Literature DB >> 2900839

Time-dependence and differential induction of rat and guinea pig peroxisomal beta-oxidation, palmitoyl-CoA hydrolase, cytosolic and microsomal epoxide hydrolase after treatment with hypolipidemic drugs.

F Oesch1, R Hartmann, C Timms, M Strolin-Benedetti, P Dostert, W Wörner, L Schladt.   

Abstract

Fischer-344 rats and Hartley guinea pigs received a diet containing 0.01% (w/w), 0.05% (w/w), or 0.25% (w/w) of the hypolipidemic drug fenofibrate. Rats were treated for 4, 7, 14, or 21 days, and a clear dose-dependent and weak time-dependent increase in liver/body weight ratio was observed. The specific activity of peroxisomal beta-oxidation increased linearly with time at all concentrations used. A dose-dependent increase in cEH was observed, but the activity remained constant after treatment for 7 days. Enhancement of palmitoyl-CoA hydrolase was dose-dependent, but was similar at all 4 time points investigated. In contrast to the other enzyme activities, mEH was not or only minimally (less than 1.5-fold) induced. In contrast to the rat, treatment of guinea pigs with fenofibrate for 1 week did not change liver weight or enzyme activities. Prolonged treatment of guinea pigs (4 weeks) with fenofibrate did not result in an increase in enzyme activities. This was also observed with clofibrate whereas tiadenol caused a slight increase in enzyme activities (1.5- to 2.6-fold). In contrast to the guinea pig each of the three hypolipidemic drugs led to an increase in enzyme activities in the rat liver after treatment for 1 week.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900839     DOI: 10.1007/bf02128176

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  Distribution and nature of epoxide hydrolase activity in subcellular organelles of mouse liver.

Authors:  S Kaur; S S Gill
Journal:  Biochem Pharmacol       Date:  1986-04-15       Impact factor: 5.858

2.  Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.

Authors:  L Schladt; R Hartmann; C Timms; M Strolin-Benedetti; P Dostert; W Wörner; F Oesch
Journal:  Biochem Pharmacol       Date:  1987-02-01       Impact factor: 5.858

3.  Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.

Authors:  R K Berge; O M Bakke
Journal:  Biochem Pharmacol       Date:  1981-08-15       Impact factor: 5.858

4.  Hydration of cis- and trans-epoxymethyl stearates by the cytosolic epoxide hydrase of mouse liver.

Authors:  S S Gill; B D Hammock
Journal:  Biochem Biophys Res Commun       Date:  1979-08-13       Impact factor: 3.575

5.  Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats.

Authors:  L Schladt; W Wörner; F Setiabudi; F Oesch
Journal:  Biochem Pharmacol       Date:  1986-10-01       Impact factor: 5.858

6.  Enhancement of fatty acyl-CoA oxidizing activity in rat liver peroxisomes by di-(i-ethylhexyl)phthalate.

Authors:  T Osumi; T Hashimoto
Journal:  J Biochem       Date:  1978-05       Impact factor: 3.387

7.  Purification and specificity of a human microsomal epoxide hydratase.

Authors:  F Oesch
Journal:  Biochem J       Date:  1974-04       Impact factor: 3.857

8.  Fenofibrate and human liver. Lack of proliferation of peroxisomes.

Authors:  P Gariot; E Barrat; L Mejean; J P Pointel; P Drouin; G Debry
Journal:  Arch Toxicol       Date:  1983-06       Impact factor: 5.153

Review 9.  Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans.

Authors:  J K Reddy; N D Lalwai
Journal:  Crit Rev Toxicol       Date:  1983       Impact factor: 5.635

10.  Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man.

Authors:  M Hanefeld; C Kemmer; E Kadner
Journal:  Atherosclerosis       Date:  1983-02       Impact factor: 5.162

View more
  2 in total

1.  Peroxisomes in guinea pig liver: their peculiar morphological features may reflect certain aspects of lipoprotein metabolism in this species.

Authors:  T Masuda; K Beier; K Yamamoto; H D Fahimi
Journal:  Cell Tissue Res       Date:  1991-01       Impact factor: 5.249

2.  Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes.

Authors:  J Pill; A Völkl; F Hartig; H D Fahimi
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.